Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorATKINSON, Andrew
dc.contributor.authorKRAUS, David
dc.contributor.authorBANHOLZER, Nicolas
dc.contributor.authorMIRO, Jose M
dc.contributor.authorREISS, Peter
dc.contributor.authorKIRK, Ole
dc.contributor.authorMUSSINI, Cristina
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMORLAT, Philippe
dc.contributor.authorPODLEKAREVA, Daria
dc.contributor.authorGRANT, Alison D
dc.contributor.authorSABIN, Caroline
dc.contributor.authorVAN DER VALK, Marc
dc.contributor.authorLE MOING, Vincent
dc.contributor.authorMEYER, Laurence
dc.contributor.authorSENG, Remonie
dc.contributor.authorCASTAGNA, Antonella
dc.contributor.authorOBEL, Niels
dc.contributor.authorANTONIADOU, Anastasia
dc.contributor.authorSALMON, Dominique
dc.contributor.authorZWAHLEN, Marcel
dc.contributor.authorEGGER, Matthias
dc.contributor.authorDE WIT, Stephane
dc.contributor.authorFURRER, Hansjakob
dc.contributor.authorFENNER, Lukas
dc.date.accessioned2024-11-20T15:00:56Z
dc.date.available2024-11-20T15:00:56Z
dc.date.issued2024-10-25
dc.identifier.issn1932-6203en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203375
dc.description.abstractEnHIV replication leads to a change in lymphocyte phenotypes that impairs immune protection against opportunistic infections. We examined current HIV replication as an independent risk factor for tuberculosis (TB). We included people living with HIV from 25 European cohorts 1983-2015. Individuals <16 years or with previous TB were excluded. Person-time was calculated from enrolment (baseline) to the date of TB diagnosis or last follow-up information. We used adjusted Poisson regression and general additive regression models. We included 272,548 people with a median follow-up of 5.9 years (interquartile range [IQR] 2.3-10.9). At baseline, the median CD4 cell count was 355 cells/μL (IQR 193-540) and the median HIV-RNA level 22,000 copies/mL (IQR 1,300-103,000). During 1,923,441 person-years of follow-up, 5,956 (2.2%) people developed TB. Overall, TB incidence was 3.1 per 1,000 person-years (95% confidence interval [CI] 3.02-3.18) and was four times higher in patients with HIV-RNA levels of 10,000 compared with levels <400 copies/mL in any CD4 stratum. CD4 and HIV-RNA time-updated analyses showed that the association between HIV-RNA and TB incidence was independent of CD4. The TB incidence rate ratio for people born in TB-endemic countries compared with those born in Europe was 1.8 (95% CI 1.5-2.2). Our results indicate that ongoing HIV replication (suboptimal HIV control) is an important risk factor for TB, independent of CD4 count. Those at highest risk of TB are people from TB-endemic countries. Close monitoring and TB preventive therapy for people with suboptimal HIV control is important.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enHumans
dc.subject.enHIV Infections
dc.subject.enMale
dc.subject.enFemale
dc.subject.enEurope
dc.subject.enAdult
dc.subject.enTuberculosis
dc.subject.enRisk Factors
dc.subject.enMiddle Aged
dc.subject.enVirus Replication
dc.subject.enCD4 Lymphocyte Count
dc.subject.enIncidence
dc.subject.enCohort Studies
dc.subject.enRNA
dc.subject.enViral
dc.title.enHIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015
dc.title.alternativePLoS Oneen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1371/journal.pone.0312035en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39453919en_US
dc.description.sponsorshipEuropeEuropean Network of HIV/AIDS Cohort Studies to Coordinate at European and International Level Clinical Research on HIV/AIDSen_US
bordeaux.journalPLoS ONEen_US
bordeaux.pagee0312035en_US
bordeaux.volume19en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue10en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAgence Nationale de Recherches sur le Sida et les Hépatites Viralesen_US
bordeaux.identifier.funderIDNational Institute of Allergy and Infectious Diseasesen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04793909
hal.version1
hal.date.transferred2024-11-20T15:00:59Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=PLoS%20ONE&amp;rft.date=2024-10-25&amp;rft.volume=19&amp;rft.issue=10&amp;rft.spage=e0312035&amp;rft.epage=e0312035&amp;rft.eissn=1932-6203&amp;rft.issn=1932-6203&amp;rft.au=ATKINSON,%20Andrew&amp;KRAUS,%20David&amp;BANHOLZER,%20Nicolas&amp;MIRO,%20Jose%20M&amp;REISS,%20Peter&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée